Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

29.98
Delayed Data
As of Feb 21
 -0.41 / -1.35%
Today’s Change
24.47
Today|||52-Week Range
41.91
-8.71%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close30.39
Today’s open30.23
Day’s range29.56 - 30.63
Volume220,313
Average volume (3 months)460,177
Market cap$1.2B
Dividend yield--
Data as of 4:02pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-40.07%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+16.14%
P/E ratio30.6
Price/Sales3.62
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.23-0.68%
AXONAxovant Sciences Ltd-0.03-0.25%
ALDRAlder Biopharmaceuti...-0.85-3.65%
ACORAcorda Therapeutics ...0.000.00%
Data as of 4:15pm ET, 02/21/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)$0.45
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts


Search for Jobs